Vivus: into single digits Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AlienTech who wrote (390)	4/25/1998 1:32:00 PM
From: Mkilloran	Read Replies (1) of 1016

AlienTech....First Mike D..now Dale..PaineWebber analyst and even Barrons today said "Anyone that has an effective drug therapy will have a nice niche" ....other potency drug's haven't given up the fight. IMO VVUS and PFE are both champs...just different weight divisions... the other companies aren't even ranked by the FDA boxing commission....Upjohn's Caverject injection is just a sparing partner...some of the others will never get in the ring.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next